Literature DB >> 2019305

Dissociation of alanine aminotransferase values in acute hepatitis A patients with and without past experience to the hepatitis B virus.

A A Papachristou1, A S Dumas, V C Katsouyannopoulos.   

Abstract

Serological markers and peak serum alanine aminotransferase (ALT) values of 140 in-patients with acute hepatitis, either type A (n = 90), or type B (n = 50) were prospectively assessed. In 23 out of the 90 patients with acute hepatitis A, evidence of previous experience with hepatitis B virus (HBV) was found, whereas 35 out of the 50 patients with acute hepatitis B had past contact with hepatitis A virus (HAV). The mean peak ALT values [S.D.] were significantly higher in hepatitis A patients with previous experience with HBV (1413 [704] i.u./l), when compared to those without such experience (842 [464] i.u./l, P less than 0.001). Such a difference was not evident between acute hepatitis B patients, whether or not they had previous contact with HAV. We conclude that when acute hepatitis A is superimposed on past HBV infection an augmented transaminaemia, indicative of enhanced liver cell necrosis, takes place although a definite explanation is lacking. We suggest that individuals with markers of HBV infection should be early candidates for HAV immunization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019305      PMCID: PMC2272000          DOI: 10.1017/s0950268800048548

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  16 in total

1.  Acute B viral hepatitis becomes fulminant after infection with hepatitis A virus.

Authors:  M Piazza; V Guadagnino; R Orlando; L Picciotto
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-26

2.  The clinical course of acute type A hepatitis in chronic HBsAg carriers--a report of 3 cases.

Authors:  L A Viola; I G Barrison; J C Coleman; I M Murray-Lyon
Journal:  Postgrad Med J       Date:  1982-02       Impact factor: 2.401

3.  Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.

Authors:  G Realdi; A Alberti; M Rugge; F Bortolotti; A M Rigoli; F Tremolada; A Ruol
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

4.  Letter: Fulminant viral hepatitis.

Authors:  M Piazza
Journal:  Lancet       Date:  1975-08-02       Impact factor: 79.321

5.  Simultaneous acute infections with hepatitis A and hepatitis B viruses in a chimpanzee.

Authors:  J Drucker; E Tabor; R J Gerety; D Jackson; L F Barker
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

6.  Histological evidence of hepatitis-B-virus infection with negative serology in children with acute leukaemia who develop chronic liver disease.

Authors:  D Vergani; A Locasciulli; G Masera; A Alberti; G Moroni; D E Tee; B Portmann; G Mieli Vergani; A L Eddleston
Journal:  Lancet       Date:  1982-02-13       Impact factor: 79.321

7.  Letter: Unresolved hepatitis in a patient with hepatitis A and B.

Authors:  M R Moser; K M Petersen; D W Bradley; K R Berquist
Journal:  Lancet       Date:  1975-10-11       Impact factor: 79.321

8.  Double infections with hepatitis A and B viruses.

Authors:  N Tassopoulos; G Papaevangelou; A Roumeliotou-Karayannis; P Kalafatas; R Engle; J Gerin; R H Purcell
Journal:  Liver       Date:  1985-12

9.  Importance of showing HBsAg and HBcAg positivity in the liver for better aetiological definition of chronic liver disease.

Authors:  L Cuccurullo; M Rambaldi; G Iaquinto; F Ferraraccio; L Ambrosone; N Giardullo; A De Vita
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

10.  Simultaneous infection with type A and B hepatitis viruses.

Authors:  S H Hindman; J E Maynard; D W Bradley; K R Berquist; A E Denes
Journal:  Am J Epidemiol       Date:  1977-02       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.